Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01568554 · ClinicalTrials.gov registry record
Clinical Diagnosis of Acute Porphyria
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 148
- Enrollment target
NCT01568554: Completed study, sponsored by University of California, San Francisco.
NCT01568554 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 148 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01568554 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 148 participants
- Enrollment target
Study Summary
The purpose of this study is to test whether a focused questionnaire and laboratory tests can better define risk factors associated with possible genetic porphyria. The investigators hypothesize that the genetic carrier state of acute porphyria is distinctive enough that the Genetic Carrier Profile the investigators devise through this study will be useful in identifying carriers of genetic porphyria among the large population with undiagnosed abdominal pain.
Primary Outcome
All subjects will be assessed for any elevation of quantitative urine porphobilinogen (PBG).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2011-12 |
| Est. Completion | 2018-12 |
What the finished NCT01568554 record still lists
NCT01568554 is an observational study that tracks outcomes without assigning an intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01568554 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01568554 about?
NCT01568554 is a clinical study titled "Clinical Diagnosis of Acute Porphyria". The purpose of this study is to test whether a focused questionnaire and laboratory tests can better define risk factors associated with possible genetic porphyria. The investigators hypothesize that the genetic carrier state of acute porphyria is distinctive enough that the Genetic Carrier Profile ...
What is the current status of trial NCT01568554?
This trial is currently completed. The enrollment target is 148 participants. The study started on 2011-12. Estimated completion is 2018-12.
Who is sponsoring clinical trial NCT01568554?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00739362 · 148 participants · Phase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
- NCT03161223 · 148 participants · Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- NCT03858231 · 148 participants · Phase 4
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
- NCT04486352 · 148 participants · Phase 1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia